Insider Transactions in Q1 2022 at Regeneron Pharmaceuticals, Inc. (REGN)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2022
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
SELL
Open market or private sale
|
Indirect |
2,886
-13.63%
|
$2,049,060
$710.01 P/Share
|
|
Mar 31
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,184
-3.91%
|
$828,800
$700.99 P/Share
|
|
Mar 31
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+4.73%
|
$598,500
$399.66 P/Share
|
|
Mar 31
2022
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,654
-14.68%
|
$6,057,800
$700.99 P/Share
|
|
Mar 31
2022
|
Christopher R. Fenimore SVP Finance & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+15.94%
|
$4,956,000
$413.05 P/Share
|
|
Mar 30
2022
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
1,240
-53.4%
|
$868,000
$700.0 P/Share
|
|
Mar 30
2022
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,240
+34.81%
|
$471,200
$380.95 P/Share
|
|
Mar 30
2022
|
P Roy Vagelos Director |
SELL
Open market or private sale
|
Indirect |
28,572
-23.98%
|
$20,000,400
$700.01 P/Share
|
|
Mar 30
2022
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
2,431
-28.56%
|
$1,701,700
$700.0 P/Share
|
|
Mar 30
2022
|
Joseph L Goldstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,431
+22.21%
|
$909,194
$374.12 P/Share
|
|
Mar 30
2022
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
408
-27.38%
|
$285,192
$699.0 P/Share
|
|
Mar 30
2022
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
408
+21.5%
|
$152,592
$374.12 P/Share
|
|
Mar 29
2022
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
1,522
-58.45%
|
$1,063,878
$699.0 P/Share
|
|
Mar 29
2022
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,522
+36.89%
|
$569,228
$374.12 P/Share
|
|
Mar 29
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
2,683
-0.63%
|
$1,845,904
$688.04 P/Share
|
|
Mar 28
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,817
-7.16%
|
$8,094,645
$685.26 P/Share
|
|
Mar 28
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,500
+7.94%
|
$6,699,000
$462.06 P/Share
|
|
Mar 21
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
7,439
-76.63%
|
$5,132,910
$690.0 P/Share
|
|
Mar 21
2022
|
Marc Tessier Lavigne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,439
+43.38%
|
$2,826,820
$380.95 P/Share
|
|
Mar 21
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
312
-1.07%
|
$215,592
$691.31 P/Share
|
|
Mar 21
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+1.36%
|
$152,400
$381.92 P/Share
|
|
Mar 21
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
300
-1.04%
|
$207,900
$693.0 P/Share
|
|
Mar 17
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
7,830
-77.53%
|
$5,324,400
$680.0 P/Share
|
|
Mar 17
2022
|
Marc Tessier Lavigne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,830
+43.67%
|
$2,944,080
$376.69 P/Share
|
|
Mar 17
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
286
-0.98%
|
$195,052
$682.5 P/Share
|
|
Mar 17
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
365
+1.23%
|
$139,065
$381.92 P/Share
|
|
Mar 17
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
83
-0.29%
|
$56,938
$686.0 P/Share
|
|
Mar 16
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
4,361
-65.78%
|
$2,943,675
$675.0 P/Share
|
|
Mar 16
2022
|
Marc Tessier Lavigne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,361
+39.68%
|
$1,631,014
$374.12 P/Share
|
|
Mar 16
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
300
-1.03%
|
$203,100
$677.0 P/Share
|
|
Mar 16
2022
|
Huda Y Zoghbi Director |
SELL
Open market or private sale
|
Direct |
2,000
-64.89%
|
$1,350,000
$675.0 P/Share
|
|
Mar 16
2022
|
Huda Y Zoghbi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+39.35%
|
$782,000
$391.92 P/Share
|
|
Mar 14
2022
|
P Roy Vagelos Director |
SELL
Payment of exercise price or tax liability
|
Direct |
48,103
-12.22%
|
$31,507,465
$655.29 P/Share
|
|
Mar 14
2022
|
P Roy Vagelos Director |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+16.0%
|
$13,425,000
$179.13 P/Share
|
|
Mar 01
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-4.84%
|
$615,000
$615.39 P/Share
|
|
Mar 01
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+4.62%
|
$342,000
$342.93 P/Share
|
|
Mar 01
2022
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$61,500
$615.47 P/Share
|
|
Feb 28
2022
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
2,000
-3.63%
|
$1,230,000
$615.5 P/Share
|
|
Feb 25
2022
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
2,000
-6.66%
|
$1,242,000
$621.0 P/Share
|
|
Feb 23
2022
|
Michael S Brown Director |
SELL
Open market or private sale
|
Indirect |
500
-6.53%
|
$304,000
$608.68 P/Share
|
|
Feb 23
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Open market or private sale
|
Direct |
6,781
-1.8%
|
$4,149,972
$612.92 P/Share
|
|
Feb 22
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Payment of exercise price or tax liability
|
Direct |
33,219
-47.07%
|
$20,263,590
$610.56 P/Share
|
|
Feb 22
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+36.17%
|
$15,960,000
$399.66 P/Share
|
|
Feb 18
2022
|
Neil Stahl EVP Research and Development |
SELL
Bona fide gift
|
Direct |
335
-0.63%
|
-
|
|
Feb 15
2022
|
Andrew J Murphy EVP Research |
SELL
Open market or private sale
|
Direct |
3,540
-0.53%
|
$2,226,660
$629.34 P/Share
|
|
Feb 14
2022
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
6,460
-9.43%
|
$4,043,960
$626.79 P/Share
|
|
Feb 14
2022
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+12.74%
|
$1,790,000
$179.13 P/Share
|
|
Feb 01
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-4.84%
|
$607,000
$607.46 P/Share
|
|
Feb 01
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+4.62%
|
$342,000
$342.93 P/Share
|
|
Feb 01
2022
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.04%
|
$60,600
$606.04 P/Share
|